Videos

Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

November 30th 2023, 9:45pm

Video

Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease to their oncology care team to facilitate early intervention and management of side effects.

Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

November 30th 2023, 9:30pm

Video

Patients on HER2-targeted therapies for HER2-positive metastatic breast cancer should be vigilant about potential side effects like heart toxicities and interstitial lung disease and should undergo regular heart function monitoring and lung scans to catch these side effects early.

Imaging Scans for Assessing HER2-Positive Breast Cancer Progression and Treatment Response

November 30th 2023, 9:15pm

Video

Imaging scans provide an invaluable method of monitoring response to HER2-positive breast cancer treatment; frequency of imaging scans depends on individual patient response, symptoms, and the need to monitor for side effects such as interstitial lung disease.

How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

November 30th 2023, 9:00pm

Video

HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.

Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

November 30th 2023, 8:40pm

Video

Treatment for HER2 low metastatic breast cancer may utilize HER2-targeted antibody-drug conjugates like T-DM1 and sacituzumab govitecan after initial therapy; knowing HER2 status, even low expression, is critical to guide use of these HER2-directed ADCs after chemotherapy.

Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

November 29th 2023, 1:30pm

Video

Treatment for HER2-negative metastatic breast cancer depends on factors like hormone receptor status, with chemo/immunotherapy for PD-L1-positive triple negative disease, PARP inhibitors for BRCA mutations, and antibody-drug conjugates as options after first line therapy.

Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer

November 29th 2023, 1:00pm

Video

Dr Sara M. Tolaney reviews the currently available treatment options for HER2-positive metastatic breast cancer and notes that many new HER2-targeting antibody-drug conjugates and bispecific antibodies are in development.

Cervical Cancer: Advocating for Yourself and Communicating With Family

November 29th 2023, 1:14am

Video

Linda Ryan, a recurrent cervical cancer survivor and patient advocate, offers advice for patients undergoing cervical cancer treatment on advocating for yourself and communicating with family.

Shared Decision-Making in Cervical Cancer

November 29th 2023, 1:10am

Video

A gynecologic medical oncologist, a registered nurse, and a patient advocate have a conversation about shared decision-making for patients with cervical cancer.

Education Crucial in Cancer, ‘One of The Most Confusing Areas of Medical Treatment’

November 24th 2023, 8:00pm

Video

As part of its Speaking Out® video series, CURE® spoke Dr. Gene G. Finley of Drexel University of College of Medicine and AHN Cancer Institute, Allegheny Clinic Medical Oncology, about education disparities among patients with lung cancer.